Pay in 4 interest-free payments of $29.75 Learn more
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15
Angiotensin 1-7 (Ang 1-7) abrogates the methylglyoxal-modified albumin (MGA)-stimulated myofibroblast phenotype by inhibiting the chronic stimulation of the TGF-β-ERK pathway in NRK-52E cells
Chemical Name: ethyl 3-{1-[2-({[4-({[(hexyloxy)carbonyl]amino}methanimidoyl)phenyl]amino}methyl)-1-methyl-1H-1
hepatocytes (HepG2)
LED209 markedly inhibits the virulence of several pathogens in animals
YM158 for LTD4 and TXA2 receptors are exhibited at the same dose range
PF-06835919 Catalog No.:M33609-C Angiotensin 1-7 (Ang 1-7) abrogatesPF 06835919, also known as MDK1846, is a potent ketohexokinase (KHK) inhibitor. PF 06835919 is reported in patent US 20170183328 A1, example 4. Increased fructose consumption and its subsequent metabolism have been implicated in hepatic steatosis, dyslipidemia, obesity, and insulin resistance in humans. Since ketohexokinase (KHK) is the principal enzyme responsible for fructose metabolism, identification of a selective KHK inhibitor may help to